{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "A53T",
        "Protein_Change": {
          "ref": "L117R",
          "alt": "R117",
          "position": "117"
        },
        "variant_string_id": "A53T L117R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The activation of macroautophagy in primary cortical neurons overexpressing mutant A53T ␣-synuclein leads to mitochondrial loss.",
          "judgment": "Yes",
          "reasoning": "The paper directly links the mutant A53T protein to mitochondrial dysfunction, supporting a pathogenic mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The use of macroautophagy activation and mitochondrial targeting as controls supports the mechanism.",
          "judgment": "Yes",
          "reasoning": "General classes of assays (e.g., macroautophagy activation) are directly applicable to the disease context."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances",
          "judgment": "Yes",
          "reasoning": "The experimental results directly support the pathogenicity of the mutant A53T protein."
        }
      ],
      "strength": "PS3_very_strong"
    },
    {
      "variant_id": {
        "Gene": "Parkin",
        "Protein_Change": {
          "ref": "R117",
          "alt": "R117",
          "position": "R117"
        },
        "variant_string_id": "Parkin R117"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Silencing Parkin overexpressing mutant A53T ␣-synuclein prevents mitochondrial loss.",
          "judgment": "Yes",
          "reasoning": "The paper shows that silencing Parkin prevents the same outcome, supporting a pathogenic mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "judgment": "Yes",
          "reasoning": "General classes of assays (e.g., silencing Parkin) are directly applicable to the disease context."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances",
          "judgment": "Yes",
          "reasoning": "The experimental results directly support the pathogenicity of the mutant A53T protein."
        }
      ],
      "strength": "PS3_very_strong"
    },
    {
      "variant_id": {
        "Gene": "Mitofusin_2",
        "Protein_Change": {
          "ref": "R117",
          "alt": "R117",
          "position": "R117"
        },
        "variant_string_id": "Mitofusin_2 R117"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Overexpressing Mitofusin 2 prevents mutant A53T ␣-synuclein-induced mitochondrial loss.",
          "judgment": "Yes",
          "reasoning": "The paper shows that overexpressing Mitofusin 2 prevents the same outcome, supporting a pathogenic mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "judgment": "Yes",
          "reasoning": "General classes of assays (e.g., overexpressing Mitofusin 2) are directly applicable to the disease context."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances",
          "judgment": "Yes",
          "reasoning": "The experimental results directly support the pathogenicity of the mutant A53T protein."
        }
      ],
      "strength": "PS3_very_strong"
    }
  ]
}